World's First Malaria Vaccine Rollout Begins in Cameroon

World's First Malaria Vaccine Rollout Begins in Cameroon
Image copyright: Getty Images/Getty Images News via Getty Images

The Facts

  • Following a 13% success rate pilot campaign in Kenya, Ghana, and Malawi, the African nation of Cameroon started the official rollout of the "RTS,S" malaria vaccine on Monday. It will be free for all children up to the age of six months old and occur alongside other routine vaccines to make it easier for parents.

  • RTS,S, also known as Mosquirix, is only about 30% effective and requires four doses, with its production estimated at up to 15M doses per year. Meanwhile, a second vaccine, which was approved by the World Health Organization (WHO) last October and is being developed at Oxford University, is reportedly cheaper, requires three doses, and could have an annual output of 200M doses.

The Spin

Pro-establishment narrative

Widespread vaccine hesitancy in Africa was exemplified during COVID, and this destructive issue has not gone away. Obstacles to successful vaccination campaigns include individual, cultural, and religious beliefs as well as the spread of misinformation. National, continental, and global institutions must build upon their pro-vaccine campaigns if they want to help African states increase inoculations and decrease deadly diseases.

Establishment-critical narrative

The patronizing tone with which global health institutions speak about Africa is astounding. Perhaps modern-day vaccine hesitancy has nothing to do with misinformation and more to do with the data. As the WHO was beginning its implied consent RTS,S vaccine rollout — meaning the recipients receiving the jab were unaware of it — they probably also didn't disclose that studies showed the vaccine to increase meningitis by 10 times and double the risk of death in girls.

Metaculus Prediction

Articles on this story

Sign up to our daily newsletter